Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies: workshop summary
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Körperschaft: | |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, District of Columbia
The National Academies Press
[2015]
|
| Schlagworte: | |
| Beschreibung: | Description based on online resource; title from PDF title page (ebrary, viewed September 4, 2015) |
| Beschreibung: | 1 online resource (106 pages) illustrations (some color) |
| ISBN: | 9780309368575 9780309368582 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV042994968 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151110s2015 |||| o||u| ||||||eng d | ||
| 020 | |a 9780309368575 |c Print |9 978-0-309-36857-5 | ||
| 020 | |a 9780309368582 |c Online |9 978-0-309-36858-2 | ||
| 035 | |a (OCoLC)934644843 | ||
| 035 | |a (DE-599)BVBBV042994968 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 110 | 2 | |a Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer (Workshop) <2014, Washington, D.C.> |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies |b workshop summary |c Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| 264 | 1 | |a Washington, District of Columbia |b The National Academies Press |c [2015] | |
| 264 | 4 | |c © 2015 | |
| 300 | |a 1 online resource (106 pages) |b illustrations (some color) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Description based on online resource; title from PDF title page (ebrary, viewed September 4, 2015) | ||
| 650 | 4 | |a Cancer |x Treatment |z United States |v Congresses | |
| 650 | 4 | |a Cancer |x Genetic aspects |v Congresses | |
| 650 | 4 | |a Biochemical markers |v Congresses | |
| 651 | 4 | |a USA | |
| 655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |2 gnd-content | |
| 700 | 1 | |a Patlak, Margie |4 aut | |
| 700 | 1 | |a Nass, Sharyl J. |4 aut | |
| 700 | 1 | |a Phillips, Jonathan |4 aut | |
| 710 | 2 | |a National Cancer Policy Forum (U.S.) |e Sonstige |4 oth | |
| 710 | 2 | |a Institute of Medicine (U.S.) |b Board on Health Care Services |e Sonstige |4 oth | |
| 912 | |a ZDB-38-EBR | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028420344 | ||
Datensatz im Suchindex
| _version_ | 1804175332066983936 |
|---|---|
| any_adam_object | |
| author | Patlak, Margie Nass, Sharyl J. Phillips, Jonathan |
| author_corporate | Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer (Workshop) <2014, Washington, D.C.> |
| author_corporate_role | aut |
| author_facet | Patlak, Margie Nass, Sharyl J. Phillips, Jonathan Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer (Workshop) <2014, Washington, D.C.> |
| author_role | aut aut aut |
| author_sort | Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer (Workshop) <2014, Washington, D.C.> |
| author_variant | m p mp s j n sj sjn j p jp |
| building | Verbundindex |
| bvnumber | BV042994968 |
| collection | ZDB-38-EBR |
| ctrlnum | (OCoLC)934644843 (DE-599)BVBBV042994968 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01878nmm a2200409zc 4500</leader><controlfield tag="001">BV042994968</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151110s2015 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309368575</subfield><subfield code="c">Print</subfield><subfield code="9">978-0-309-36857-5</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309368582</subfield><subfield code="c">Online</subfield><subfield code="9">978-0-309-36858-2</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)934644843</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV042994968</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="110" ind1="2" ind2=" "><subfield code="a">Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer (Workshop) <2014, Washington, D.C.></subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies</subfield><subfield code="b">workshop summary</subfield><subfield code="c">Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Washington, District of Columbia</subfield><subfield code="b">The National Academies Press</subfield><subfield code="c">[2015]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2015</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (106 pages)</subfield><subfield code="b">illustrations (some color)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (ebrary, viewed September 4, 2015)</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Genetic aspects</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biochemical markers</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Patlak, Margie</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nass, Sharyl J.</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Phillips, Jonathan</subfield><subfield code="4">aut</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">National Cancer Policy Forum (U.S.)</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.)</subfield><subfield code="b">Board on Health Care Services</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-38-EBR</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028420344</subfield></datafield></record></collection> |
| genre | (DE-588)1071861417 Konferenzschrift gnd-content |
| genre_facet | Konferenzschrift |
| geographic | USA |
| geographic_facet | USA |
| id | DE-604.BV042994968 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T07:14:36Z |
| institution | BVB |
| isbn | 9780309368575 9780309368582 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028420344 |
| oclc_num | 934644843 |
| open_access_boolean | |
| physical | 1 online resource (106 pages) illustrations (some color) |
| psigel | ZDB-38-EBR |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | The National Academies Press |
| record_format | marc |
| spelling | Policy Issues in the Development and Adoption of Molecularly Targeted Therapies for Cancer (Workshop) <2014, Washington, D.C.> Verfasser aut Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies workshop summary Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies Washington, District of Columbia The National Academies Press [2015] © 2015 1 online resource (106 pages) illustrations (some color) txt rdacontent c rdamedia cr rdacarrier Description based on online resource; title from PDF title page (ebrary, viewed September 4, 2015) Cancer Treatment United States Congresses Cancer Genetic aspects Congresses Biochemical markers Congresses USA (DE-588)1071861417 Konferenzschrift gnd-content Patlak, Margie aut Nass, Sharyl J. aut Phillips, Jonathan aut National Cancer Policy Forum (U.S.) Sonstige oth Institute of Medicine (U.S.) Board on Health Care Services Sonstige oth |
| spellingShingle | Patlak, Margie Nass, Sharyl J. Phillips, Jonathan Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies workshop summary Cancer Treatment United States Congresses Cancer Genetic aspects Congresses Biochemical markers Congresses |
| subject_GND | (DE-588)1071861417 |
| title | Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies workshop summary |
| title_auth | Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies workshop summary |
| title_exact_search | Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies workshop summary |
| title_full | Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies workshop summary Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_fullStr | Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies workshop summary Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_full_unstemmed | Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies workshop summary Sharyl J. Nass, Jonathan Phillips, and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies |
| title_short | Policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies |
| title_sort | policy issues in the development and adoption of biomarkers for molecularly targeted cancer therapies workshop summary |
| title_sub | workshop summary |
| topic | Cancer Treatment United States Congresses Cancer Genetic aspects Congresses Biochemical markers Congresses |
| topic_facet | Cancer Treatment United States Congresses Cancer Genetic aspects Congresses Biochemical markers Congresses USA Konferenzschrift |
| work_keys_str_mv | AT policyissuesinthedevelopmentandadoptionofmolecularlytargetedtherapiesforcancerworkshop2014washingtondc policyissuesinthedevelopmentandadoptionofbiomarkersformolecularlytargetedcancertherapiesworkshopsummary AT patlakmargie policyissuesinthedevelopmentandadoptionofbiomarkersformolecularlytargetedcancertherapiesworkshopsummary AT nasssharylj policyissuesinthedevelopmentandadoptionofbiomarkersformolecularlytargetedcancertherapiesworkshopsummary AT phillipsjonathan policyissuesinthedevelopmentandadoptionofbiomarkersformolecularlytargetedcancertherapiesworkshopsummary AT nationalcancerpolicyforumus policyissuesinthedevelopmentandadoptionofbiomarkersformolecularlytargetedcancertherapiesworkshopsummary AT instituteofmedicineusboardonhealthcareservices policyissuesinthedevelopmentandadoptionofbiomarkersformolecularlytargetedcancertherapiesworkshopsummary |